풍진 백신 시장 : 동향, 예측 및 경쟁 분석(-2030년)

Rubella Vaccine Trends and Forecast

The future of the global rubella vaccine market looks promising with opportunities in the hospital, NGO, and pediatric clinic markets. The global rubella vaccine market is expected to reach an estimated $245.0 million by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are growing demand for combination vaccines and rising adoption of rubella vaccination programs in developing countries.

A more than 150-page report is developed to help in your business decisions.

Rubella Vaccine by Segment

The study includes a forecast for the global rubella vaccine by type, end use, and region.

Rubella Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Monovalent Formulation
• Measles-Rubella Vaccine
• Measles, Mumps, Rubella Vaccine
• Measles Mumps Rubella Varicella Vaccine

Rubella Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• NGO'S
• Pediatric Clinics
• Others

Rubella Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Rubella Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rubella vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rubella vaccine companies profiled in this report include-

• Johnson & Johnson
• Sanofi Pasteur
• Bavarian Nordic
• Medimmune
• China National Biotec
• Glaxosmithkline
• Pfizer

Rubella Vaccine Market Insights

Lucintel forecasts that measles-rubella vaccine is expected to witness highest growth over the forecast period due to it growing usage to protect against two highly contagious diseases including measles and rubella.

North America is expected to witness highest growth over the forecast perioddue to high vaccination coverage rates and presence of key manufacturer in the region.

Features of the Global Rubella Vaccine Market

Market Size Estimates: Rubella vaccine market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rubella vaccine market size by type, end use, and region in terms of value ($M).

Regional Analysis: Rubella vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the rubella vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rubella vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rubella vaccine market size?

Answer: The global rubella vaccine market is expected to reach an estimated $245.0 million by 2030.

Q.2 What is the growth forecast for rubella vaccine market?

Answer: The global rubella vaccine market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rubella vaccine market?

Answer: The major drivers for this market are growing demand for combination vaccines and rising adoption of rubella vaccination programs in developing countries.

Q4. What are the major segments for rubella vaccine market?

Answer: The future of the rubella vaccine market looks promising with opportunities in the hospital, NGO, and pediatric clinic markets.

Q5. Who are the key rubella vaccine market companies?

Answer: Some of the key rubella vaccine companies are as follows:

• Johnson & Johnson
• Sanofi Pasteur
• Bavarian Nordic
• Medimmune
• China National Biotec
• Glaxosmithkline
• Pfizer

Q6. Which rubella vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that measles-rubella vaccine is expected to witness highest growth over the forecast period due to it growing usage to protect against two highly contagious diseases including measles and rubella.

Q7. In rubella vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to high vaccination coverage rates and presence of key manufacturer in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rubella vaccine market by type (monovalent formulation, measles-rubella vaccine, measles, mumps, rubella vaccine, and measles mumps rubella varicella vaccine), end use (hospitals, NGO's, pediatric clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rubella Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Rubella Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Rubella Vaccine Market by Type
  • 3.3.1: Monovalent Formulation
  • 3.3.2: Measles-Rubella Vaccine
  • 3.3.3: Measles, Mumps, Rubella Vaccine
  • 3.3.4: Measles Mumps Rubella Varicella Vaccine
• 3.4: Global Rubella Vaccine Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: NGO's
  • 3.4.3: Pediatric Clinics
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Rubella Vaccine Market by Region
• 4.2: North American Rubella Vaccine Market
  • 4.2.2: North American Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
• 4.3: European Rubella Vaccine Market
  • 4.3.1: European Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
  • 4.3.2: European Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
• 4.4: APAC Rubella Vaccine Market
  • 4.4.1: APAC Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
  • 4.4.2: APAC Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
• 4.5: ROW Rubella Vaccine Market
  • 4.5.1: ROW Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
  • 4.5.2: ROW Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rubella Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Rubella Vaccine Market by End Use
  • 6.1.3: Growth Opportunities for the Global Rubella Vaccine Market by Region
• 6.2: Emerging Trends in the Global Rubella Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rubella Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rubella Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Johnson & Johnson
• 7.2: Sanofi Pasteur
• 7.3: Bavarian Nordic
• 7.4: MedImmune
• 7.5: China National Biotec
• 7.6: GlaxoSmithKline
• 7.7: Pfizer